Shanghai, China · Founded 2013 · Privately Held (backing)
Developer of hypertension interventional devices designed for medical health. Brattea is based in Shanghai, China and was founded in 2013. Its last reported valuation was $422 million in Feb 2025. It has raised $144 million.
Last reported valuation
$422.3M
Oct 2026
Priced at
—
Total raised
$144.3M
Last round
—
Team — not yet on record
No current team members for Brattea are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Brattea with a free account
·The complete investor list: 20 names
·Watch Brattea: the Monday email on marks, rounds and moves
